131 related articles for article (PubMed ID: 11828259)
1. Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays.
de Wit NJ; Burtscher HJ; Weidle UH; Ruiter DJ; van Muijen GN
Melanoma Res; 2002 Feb; 12(1):57-69. PubMed ID: 11828259
[TBL] [Abstract][Full Text] [Related]
2. Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays.
de Wit NJ; Rijntjes J; Diepstra JH; van Kuppevelt TH; Weidle UH; Ruiter DJ; van Muijen GN
Br J Cancer; 2005 Jun; 92(12):2249-61. PubMed ID: 15900300
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
4. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays.
Nambiar S; Mirmohammadsadegh A; Doroudi R; Gustrau A; Marini A; Roeder G; Ruzicka T; Hengge UR
Arch Dermatol; 2005 Feb; 141(2):165-73. PubMed ID: 15724012
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.
Rumpler G; Becker B; Hafner C; McClelland M; Stolz W; Landthaler M; Schmitt R; Bosserhoff A; Vogt T
Exp Dermatol; 2003 Dec; 12(6):761-71. PubMed ID: 14714555
[TBL] [Abstract][Full Text] [Related]
6. Identification of metastasis-associated genes by transcriptional profiling of a metastasizing versus a non-metastasizing human melanoma cell line.
Brem R; Hildebrandt T; Jarsch M; Van Muijen GN; Weidle UH
Anticancer Res; 2001; 21(3B):1731-40. PubMed ID: 11497253
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma.
Kunz M; Koczan D; Ibrahim SM; Gillitzer R; Gross G; Thiesen HJ
Acta Derm Venereol; 2002; 82(3):163-9. PubMed ID: 12353704
[TBL] [Abstract][Full Text] [Related]
8. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
[TBL] [Abstract][Full Text] [Related]
9. Molecular determinants of human uveal melanoma invasion and metastasis.
Seftor EA; Meltzer PS; Kirschmann DA; Pe'er J; Maniotis AJ; Trent JM; Folberg R; Hendrix MJ
Clin Exp Metastasis; 2002; 19(3):233-46. PubMed ID: 12067204
[TBL] [Abstract][Full Text] [Related]
10. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
11. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
12. Isolation of invasion-associated cDNAs in melanoma.
Gütgemann A; Golob M; Müller S; Buettner R; Bosserhoff AK
Arch Dermatol Res; 2001 Jun; 293(6):283-90. PubMed ID: 11480587
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development.
Hummerich L; Müller R; Hess J; Kokocinski F; Hahn M; Fürstenberger G; Mauch C; Lichter P; Angel P
Oncogene; 2006 Jan; 25(1):111-21. PubMed ID: 16247483
[TBL] [Abstract][Full Text] [Related]
14. New developments in the staging of melanoma.
Baruch AC; Shi J; Feng Y; Nelson MA
Cancer Invest; 2005; 23(6):561-7. PubMed ID: 16203664
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development.
Zuidervaart W; van der Velden PA; Hurks MH; van Nieuwpoort FA; Out-Luiting CJ; Singh AD; Frants RR; Jager MJ; Gruis NA
Br J Cancer; 2003 Nov; 89(10):1914-9. PubMed ID: 14612903
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells.
Cheng SL; Huang Liu R; Sheu JN; Chen ST; Sinchaikul S; Tsay GJ
Biol Pharm Bull; 2006 Apr; 29(4):655-69. PubMed ID: 16595896
[TBL] [Abstract][Full Text] [Related]
17. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR.
Dooley TP; Reddy SP; Wilborn TW; Davis RL
Biochem Biophys Res Commun; 2003 Jul; 306(4):1026-36. PubMed ID: 12821146
[TBL] [Abstract][Full Text] [Related]
20. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
